As news continues to break about GlaxoSmithKline’s (“GSK”) anti-nausea drug Zofran (ondansetron) and its propensity to cause birth defects, numerous lawsuits are being filed against the drug company alleging it failed to properly warn patients of Zofran’s (ondansetron) devastating side effects. Originally created by GSK to treat nausea and vomiting in cancer patients—and not approved by the FDA for use in pregnant women—Zofran (ondansetron) has been found to cause a 2.37 increase in risk of cleft palate in infants exposed to the drug during the first trimester. Another study out of the medical journal Reproductive Toxicology found that Zofran (ondansetron) can cause congenital heart malformations.
Several new cases were filed in June 2015, including two cases filed by Grant & Eisenhofer. The first of those cases was filed in the Southern District of Alabama on behalf of Vicki Roberts and her child. The complaint alleges that Robert’s daughter’s congenital heart defects were caused by Zofran, necessitating a pacemaker that will be surgically removed and replaced many times throughout her lifetime. The second case was filed in Louisiana district court with claims that Zofran (ondansetron) caused Alexis Alexander’s son’s heart defects, requiring two surgeries to correct.
If you or a loved one took Zofran (ondansetron) for morning sickness during pregnancy and if your child was born with a congenital heart defect or cleft palate, call us today at 877-978-0169 for a free, private discussion of your potential claim.